IBDEI0DE ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18098,0)
 ;;=V10.47^^110^1109^72
 ;;^UTILITY(U,$J,358.3,18098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18098,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,18098,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,18098,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,18099,0)
 ;;=V10.83^^110^1109^70
 ;;^UTILITY(U,$J,358.3,18099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18099,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,18099,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,18099,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,18100,0)
 ;;=285.22^^110^1109^8
 ;;^UTILITY(U,$J,358.3,18100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18100,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,18100,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,18100,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,18101,0)
 ;;=285.21^^110^1109^9
 ;;^UTILITY(U,$J,358.3,18101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18101,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,18101,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,18101,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,18102,0)
 ;;=285.29^^110^1109^10
 ;;^UTILITY(U,$J,358.3,18102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18102,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,18102,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,18102,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,18103,0)
 ;;=284.9^^110^1109^11
 ;;^UTILITY(U,$J,358.3,18103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18103,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,18103,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,18103,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,18104,0)
 ;;=282.61^^110^1109^76
 ;;^UTILITY(U,$J,358.3,18104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18104,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,18104,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,18104,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,18105,0)
 ;;=282.7^^110^1109^75
 ;;^UTILITY(U,$J,358.3,18105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18105,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,18105,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,18105,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,18106,0)
 ;;=283.9^^110^1109^78
 ;;^UTILITY(U,$J,358.3,18106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18106,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,18106,1,5,0)
 ;;=5^Hemolytic Anemia, Acquired
 ;;^UTILITY(U,$J,358.3,18106,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,18107,0)
 ;;=283.0^^110^1109^79
 ;;^UTILITY(U,$J,358.3,18107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18107,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,18107,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,18107,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,18108,0)
 ;;=282.9^^110^1109^77
 ;;^UTILITY(U,$J,358.3,18108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18108,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,18108,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,18108,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,18109,0)
 ;;=283.19^^110^1109^80
 ;;^UTILITY(U,$J,358.3,18109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18109,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,18109,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,18109,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,18110,0)
 ;;=280.9^^110^1109^82
 ;;^UTILITY(U,$J,358.3,18110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18110,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,18110,1,5,0)
 ;;=5^Iron Defic Anemia NOS
 ;;^UTILITY(U,$J,358.3,18110,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,18111,0)
 ;;=285.1^^110^1109^83
 ;;^UTILITY(U,$J,358.3,18111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18111,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,18111,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,18111,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,18112,0)
 ;;=280.0^^110^1109^84
 ;;^UTILITY(U,$J,358.3,18112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18112,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,18112,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,18112,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,18113,0)
 ;;=281.9^^110^1109^105
 ;;^UTILITY(U,$J,358.3,18113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18113,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,18113,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,18113,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,18114,0)
 ;;=281.0^^110^1109^121
 ;;^UTILITY(U,$J,358.3,18114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18114,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,18114,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,18114,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,18115,0)
 ;;=282.60^^110^1109^109
 ;;^UTILITY(U,$J,358.3,18115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18115,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,18115,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,18115,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,18116,0)
 ;;=282.62^^110^1109^110
 ;;^UTILITY(U,$J,358.3,18116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18116,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,18116,1,5,0)
 ;;=5^Sickle-Cell w/ Crisis
 ;;^UTILITY(U,$J,358.3,18116,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,18117,0)
 ;;=281.1^^110^1109^120
 ;;^UTILITY(U,$J,358.3,18117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18117,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,18117,1,5,0)
 ;;=5^Vit B12 Deficiency (Dietary)
 ;;^UTILITY(U,$J,358.3,18117,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,18118,0)
 ;;=286.7^^110^1109^52
 ;;^UTILITY(U,$J,358.3,18118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18118,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,18118,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,18118,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,18119,0)
 ;;=289.9^^110^1109^117
 ;;^UTILITY(U,$J,358.3,18119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18119,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,18119,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,18119,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,18120,0)
 ;;=451.9^^110^1109^118
 ;;^UTILITY(U,$J,358.3,18120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18120,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,18120,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,18120,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,18121,0)
 ;;=446.6^^110^1109^119
 ;;^UTILITY(U,$J,358.3,18121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18121,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,18121,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,18121,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,18122,0)
 ;;=286.4^^110^1109^122
 ;;^UTILITY(U,$J,358.3,18122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18122,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,18122,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,18122,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,18123,0)
 ;;=204.00^^110^1109^1
 ;;^UTILITY(U,$J,358.3,18123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18123,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,18123,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,18123,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,18124,0)
 ;;=204.01^^110^1109^3
 ;;^UTILITY(U,$J,358.3,18124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18124,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,18124,1,5,0)
 ;;=5^ALL, In Remission
 ;;^UTILITY(U,$J,358.3,18124,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,18125,0)
 ;;=204.10^^110^1109^46
 ;;^UTILITY(U,$J,358.3,18125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18125,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,18125,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,18125,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,18126,0)
 ;;=204.11^^110^1109^47
 ;;^UTILITY(U,$J,358.3,18126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18126,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,18126,1,5,0)
 ;;=5^CLL, In Remission
 ;;^UTILITY(U,$J,358.3,18126,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,18127,0)
 ;;=202.41^^110^1109^74
 ;;^UTILITY(U,$J,358.3,18127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18127,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,18127,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,18127,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,18128,0)
 ;;=201.90^^110^1109^81
 ;;^UTILITY(U,$J,358.3,18128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18128,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,18128,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,18128,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,18129,0)
 ;;=785.6^^110^1109^87
 ;;^UTILITY(U,$J,358.3,18129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18129,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,18129,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,18129,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,18130,0)
 ;;=200.20^^110^1109^90
 ;;^UTILITY(U,$J,358.3,18130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18130,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,18130,1,5,0)
 ;;=5^Lymphoma,Burkitt's,Site Unspec
 ;;^UTILITY(U,$J,358.3,18130,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,18131,0)
 ;;=202.00^^110^1109^89
 ;;^UTILITY(U,$J,358.3,18131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18131,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,18131,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Site Unspec
 ;;^UTILITY(U,$J,358.3,18131,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,18132,0)
 ;;=200.10^^110^1109^88
 ;;^UTILITY(U,$J,358.3,18132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18132,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,18132,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Site Unspec
 ;;^UTILITY(U,$J,358.3,18132,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,18133,0)
 ;;=273.3^^110^1109^91
 ;;^UTILITY(U,$J,358.3,18133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18133,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,18133,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,18133,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,18134,0)
 ;;=203.00^^110^1109^104
 ;;^UTILITY(U,$J,358.3,18134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18134,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,18134,1,5,0)
 ;;=5^Multiple Myeloma w/o Rem
